GlassScriptPhysician profile
Parul S Patel
NPI 1528262870
$3,258.31
in general payments reported to CMS, 2019-2025
12 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.31 · 2021: $148 · 2022: $2,399 · 2023: $146 · 2024: $415 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674 · Education: $6.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.40 |
| Education | $6.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $2,309.87 | 2022 | |
| Sanofi-Aventis U.S. LLC | $267.03 | 2024-2025 | |
| Medtronic, INC. | $160.53 | 2023-2024 | Minimed 780g |
| Ucb, INC. | $125.00 | 2023 | |
| Novo Nordisk INC | $121.84 | 2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2021 | |
| Dexcom, INC. | $88.84 | 2022 | |
| Veloxis Pharmaceuticals, INC. | $31.31 | 2019 | |
| Eton Pharmaceuticals, INC. | $21.79 | 2021 | |
| Sanofi Pasteur INC. | $13.33 | 2021 | |
| Insulet Corporation | $12.62 | 2021 | |
| Travere Therapeutics, INC. | $6.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.